文献速递MDS 与骨髓增殖性肿瘤白血病

慢性粒单核细胞白血病骨髓间充质干细胞的WNT/β-catenin信号过度激活及功能异常

Bone marrow mesenchymal stromal cells in chronic myelomonocytic leukaemia: overactivated WNT/β-catenin signalling by parallel RNA sequencing and dysfunctional phenotypes.
PubMed 文献 · Br J Haematol · 2021-05-06

本研究首次采用平行RNA测序方法,在24例慢性粒单核细胞白血病(CMML)患者队列中探究骨髓间充质干细胞(BM MSCs)的转录谱和功能缺陷。结果发现WNT/β-catenin信号显著富集,CTNNB1、CMYC、LEF1和FRZB表达失调,与CMML MSCs增殖受损、衰老表型及异常分泌相关;支持健康CD34+造血干祖细胞的能力受损与WNT/β-catenin信号激活相关。此外,WNT/β-catenin因子与MDS/MPN患者对去甲基化药物(HMAs)的治疗反应存在关联。

要点

  • CMML患者BM MSCs存在WNT/β-catenin信号过度激活及转录功能异常。
  • WNT因子失调与MSCs增殖受损、衰老及支持HSPC能力下降相关。
  • WNT/β-catenin因子或与CMML患者预后及HMAs治疗反应相关。

核心结论

  • CMML患者骨髓间充质干细胞存在转录和功能异常,WNT/β-catenin信号过度激活,评估该信号可能具有预后价值。

研究设计与样本

  • 利用平行RNA测序方法,研究24例CMML患者原代骨髓间充质干细胞的转录谱和功能缺陷。

主要发现

  • CMML MSCs中WNT/β-catenin信号显著富集,涉及多个生物学过程。
  • WNT/β-catenin因子CTNNB1、CMYC、LEF1和FRZB表达失调,与CMML MSCs增殖受损、衰老表型及异常分泌相关。
  • CMML MSCs支持健康CD34+造血干祖细胞的能力受损,与WNT/β-catenin信号激活相关。
  • WNT/β-catenin因子与MDS/MPN患者对去甲基化药物(HMAs)的治疗反应存在关联。

临床怎么用

  • 可考虑评估CMML患者骨髓间充质干细胞的WNT/β-catenin信号,作为潜在的预后或治疗反应参考。

局限性

  • 研究队列仅24例CMML患者,样本量有限。
  • WNT/β-catenin因子与HMAs治疗反应的关联在MDS/MPN队列中观察,非CMML专属验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sophisticated cross-talk between bone marrow mesenchymal stromal cells (BM MSCs) and haematopoietic/leukaemic stem cells in patients with myelodysplastic syndromes (MDS) and myeloid leukaemia have been emphasized in previous reports. However, mesenchymal elements in patients with chronic myelomonocytic leukaemia (CMML) were poorly investigated. By utilizing a parallel RNA-sequencing method, we investigated the transcriptional profile and functional defects of primary BM MSCs from patients with CMML for the first time. Within a 24-patient cohort, transcriptional and functional analysis reveals a prominent enrichment of WNT/β-catenin signalling and multiple biology processes. Deregulated expression of WNT/β-catnin factors CTNNB1, CMYC, LEF1, and FRZB is associated with impaired proliferation, senescence phenotype, and abnormal secretion in CMML MSCs. The impaired ability to support healthy CD34+ haematopoietic stem and progenitor cells (HSPCs) correlates with activation of WNT/β-catenin signalling in CMML MSCs. Furthermore, we observed an association between WNT/β-catenin factors and treatment response to hypomethylating agents (HMAs) in a cohort of patients with MDS/myeloproliferative neoplasms (MPNs). Taken together, our study provides evidence for transcriptional and functional abnormalities in CMML MSCs, and suggests potential prognostic value of evaluating WNT/β-catenin signalling in patients with CMML.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Xu R, Huang X, Li C, et al. Bone marrow mesenchymal stromal cells in chronic myelomonocytic leukaemia: overactivated WNT/β-catenin signalling by parallel RNA sequencing and dysfunctional phenotypes. Br J Haematol. 2021. PMID: 33959953. doi:10.1111/bjh.17425

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。